Difficulty: Medium
Average Score: 79%
Practice
Jaundice appearing on day of life suggests all of the above EXCEPT
Correct answer
D
Rationale
In this question, the correct answer is option D) Fetal-to-maternal transfusion. Jaundice appearing on the first day of life is suggestive of pathological causes of hyperbilirubinemia in newborns. Fetal-to-maternal transfusion typically presents with jaundice within the first 24 hours.
Option A) TORCH infections are a group of infections that can cause fetal anomalies but typically present with jaundice after the first day of life.
Option B) Erythroblastosis fetalis, also known as hemolytic disease of the newborn, is caused by Rh or other blood group incompatibility between the mother and fetus. Jaundice in this condition usually appears after the first day.
Option C) ABO incompatibility can also lead to hemolytic disease of the newborn but, like erythroblastosis fetalis, the jaundice usually appears after the first day.
Educationally, understanding the timing of jaundice onset in newborns is crucial for pediatric nurses to differentiate between various causes and provide appropriate care. Early recognition of fetal-to-maternal transfusion can prompt timely interventions to manage hyperbilirubinemia and prevent complications in the newborn.
Option A) TORCH infections are a group of infections that can cause fetal anomalies but typically present with jaundice after the first day of life.
Option B) Erythroblastosis fetalis, also known as hemolytic disease of the newborn, is caused by Rh or other blood group incompatibility between the mother and fetus. Jaundice in this condition usually appears after the first day.
Option C) ABO incompatibility can also lead to hemolytic disease of the newborn but, like erythroblastosis fetalis, the jaundice usually appears after the first day.
Educationally, understanding the timing of jaundice onset in newborns is crucial for pediatric nurses to differentiate between various causes and provide appropriate care. Early recognition of fetal-to-maternal transfusion can prompt timely interventions to manage hyperbilirubinemia and prevent complications in the newborn.